touchPODCAST

touchPODCAST

Por: touchpodcast
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.

Educating physicians on a fully global scale since 2005!

We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.

Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates

Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY

This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
522 episodios disponibles

Latest episodes of the podcast touchPODCAST

Mostrando página 5 de 27

Primary biliary cholangitis: Appraising the changing therapeutic landscape 14/11/2024
Primary biliary cholangitis: Appraising the changing therapeutic landscape 14/11/2024
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4 14/11/2024
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3 14/11/2024
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4 14/11/2024
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3 14/11/2024
touchMDT for touchRESPIRATORY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? 13/11/2024
touchMDT for touchRESPIRATORY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? 13/11/2024
touchMDT for touchRESPIRATORY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? 13/11/2024
touchMDT for touchONCOLOGY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? 13/11/2024
touchMDT for touchONCOLOGY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? 13/11/2024
touchMDT for touchONCOLOGY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? 13/11/2024
Vaccination strategies for pneumococcal disease 05/11/2024
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024 28/10/2024
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024 28/10/2024
Pharmacological management of agitation in Alzheimer's dementia 24/10/2024
touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchCARDIO 24/10/2024
touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchRESPIRATORY 24/10/2024
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 1 16/10/2024
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 2 16/10/2024
« Primera ‹ Anterior 1 ... 3 4 5 6 7 ... 27 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA